Back to News Page
Source: Indianapolis Business Journal
Precision Care Technologies, acquired by Boomerang Ventures, is transforming soft tissue therapy with patented technology that delivers real-time, measurable metrics to clinicians. Led by CEO Jennifer Holmes, the company aims to bring objectivity to manual therapy in physical rehabilitation and sports medicine.
Source: Morningstar
In a recent Morningstar article, Boomerang Ventures portfolio company Mentavi Health is featured for its groundbreaking study validating an online assessment tool for diagnosing adult ADHD. The study, presented at a major international conference, demonstrates that Mentavi’s asynchronous, web-based assessment performs comparably to traditional clinical evaluations, offering a more accessible and efficient diagnostic option.
Source: Modern Healthcare
Boomerang Ventures portfolio company GEOH is featured in Modern Healthcare for its role in advancing revenue cycle management (RCM) to support value-based care success. The article highlights how GEOH and others are streamlining administrative tasks to improve care continuity and outcomes, aligning with the future of healthcare delivery.
Source: Indianapolis Business Journal
The Trump administration’s decision to cut 3,500 FDA jobs is stirring concern among Indianapolis-based companies that rely on the agency for product approvals and regulatory clarity. While federal officials say inspections and reviews will be unaffected, local medical device and software firms report anxiety over potential delays, investor hesitation, and confusion about shifting FDA protocols—especially around AI-enabled technologies. Health tech leaders from Greenlight Guru, Boomerang Ventures, and Eagle Creek Consultants weigh in on the ripple effects of the shakeup.
Source: Business Insider
Boomerang Ventures portfolio company HabitHalo was recently featured in Business Insider for the launch of its Quit Vaping App, a one-time purchase tool that delivers data-driven support to help users reduce or quit nicotine use. The article highlights the app’s personalized approach, real-time tracking, and science-backed foundation built by founder Phil Tran and the HabitHalo team.
Source: Business Insider
After sending 500 cold emails, Tejas Vijh found the rare combination of a U.S. venture capital firm willing to sponsor his visa and genuinely support his journey as an immigrant. While many international students gravitate toward Big Tech for perceived stability, Vijh found greater security, mentorship, and long-term opportunity at a small VC firm that valued his commitment and potential.
Source: TechPoint
TechPoint featured HabitHalo, a Boomerang Ventures portfolio company, for the launch of its Quit Vaping App. The article spotlights HabitHalo’s mission to empower users with real-time tracking, personalized plans, and motivational tools to support a nicotine-free life. Designed by founder Phil Tran and supported by Boomerang Ventures, the app is a meaningful step forward in connected health innovation.
HabitHalo, a Boomerang Ventures portfolio company, has launched the HabitHalo: Quit Vaping App—a $9.99 one-time purchase that delivers personalized, data-driven tools to help users monitor, reduce, or quit nicotine use. With features like puff tracking, intelligent sleep mode, and motivational cues, the app offers a smarter, science-backed approach to vaping cessation.
By: Tejas Vijh, Investment Team Member, Boomerang Ventures
AI is not replacing human insight in venture capital—it’s enhancing it. From deal sourcing and due diligence to portfolio management and trendspotting, AI tools like Affinity, PitchBook, and ChatGPT are reshaping how investors operate. By streamlining workflows, mitigating bias, and offering predictive insights, AI empowers firms to make smarter, data-driven decisions.
Source: Business Insider
Business Insider reports that Precision Care Technologies, a Boomerang Ventures portfolio company, has appointed Jennifer Holmes as CEO. Holmes brings three decades of executive leadership in the medical device and MedTech sectors, having held positions at Boston Scientific, Guidant Corporation (Abbott), Spectranetics (Philips), MedAssets (Vizient), and Central Logic (ABOUT Healthcare). Her expertise is expected to drive the commercialization and growth of the company’s Quantifiable Soft Tissue Manipulation (QSTM) technology.
Back to News Page
Hq0 Bldg., Ste H108
Indianapolis, IN 46202
General Inquiries
Collaborate With Boomerang Studios